This inventor holds 2 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Kanchanapally Tejaswini: Innovator in Anti-Cancer Research
Introduction
Kanchanapally Tejaswini is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of anti-cancer research through his innovative work on nimbolide analogs. With a total of 2 patents to his name, Tejaswini is recognized for his dedication to advancing medical science.
Latest Patents
Tejaswini's latest patents focus on nimbolide analogs as anti-cancer agents. The inventions relate to the preparation of these analogs, which are useful in combating cancer. The general formula I of these nimbolide analogs includes various rings and substituents, such as substituted or unsubstituted aryl, heteroaryl, cycloalkyl, and heterocyclic structures. The compounds are designed to include a range of functional groups, enhancing their potential effectiveness as therapeutic agents.
Career Highlights
Tejaswini is affiliated with the Council of Scientific and Industrial Research, where he conducts his research. His work is characterized by a commitment to developing innovative solutions for complex health challenges. His contributions have been instrumental in the ongoing fight against cancer.
Collaborations
Tejaswini has collaborated with esteemed colleagues, including Srivari Chandrasekhar and Prathama Satyendra Mainkar. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their projects.
Conclusion
Kanchanapally Tejaswini stands out as a dedicated inventor in the field of anti-cancer research. His innovative work on nimbolide analogs showcases his commitment to improving health outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
